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Abstract
The Eph receptor tyrosine kinases (RTKs) are regulators of cell migration and axon guidance. However, our understanding of
the molecular mechanisms by which Eph RTKs regulate these processes is still incomplete. To understand how Eph
receptors regulate axon guidance in Caenorhabditis elegans, we screened for suppressors of axon guidance defects caused
by a hyperactive VAB-1/Eph RTK. We identified NCK-1 and WSP-1/N-WASP as downstream effectors of VAB-1. Furthermore,
VAB-1, NCK-1, and WSP-1 can form a complex in vitro. We also report that NCK-1 can physically bind UNC-34/Enabled (Ena),
and suggest that VAB-1 inhibits the NCK-1/UNC-34 complex and negatively regulates UNC-34. Our results provide a model
of the molecular events that allow the VAB-1 RTK to regulate actin dynamics for axon guidance. We suggest that VAB-1/Eph
RTK can stop axonal outgrowth by inhibiting filopodia formation at the growth cone by activating Arp2/3 through a VAB-1/
NCK-1/WSP-1 complex and by inhibiting UNC-34/Ena activity.
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Introduction
During development, axons navigate to their final destination
by interpreting extracellular guidance cues through their growth
cone. The Eph receptor tyrosine kinases (RTKs) and their ephrin
ligands are involved in directing axons to their proper location
[1,2]. Studies in vertebrate systems have identified a number of
effectors in the Eph RTKs signaling pathway in axon guidance
[2]. However, the molecular mechanism of how Eph RTKs
regulate axon guidance is still incomplete. This is partly due to the
large number of Ephrins and Eph RTKs that can engage in
crosstalk [2,3]. The presence of a single Eph RTK, VAB-1, in
Caenorhabditis elegans can simplify the analysis of the signal
transduction events from the receptor. The C. elegans VAB-1
Eph RTK is required for various aspects of neuronal development,
including neuroblast movements, and axon guidance [4,5,6,7].
The molecules involved in VAB-1 signaling in axon guidance are
still unknown. To resolve this issue, we used a genetic suppressor
approach as well as a physical protein interaction approach and
identified NCK-1, WSP-1/N-WASP, UNC-34/Ena, and the
Arp2/3 complex as molecules regulated by VAB-1 signaling in
axon guidance.
The Nck adaptor proteins are known actin cytoskeleton
regulators, and have been shown to function downstream of
several axon guidance receptors including Robo, Dcc and the Eph
RTKs [8,9,10,11]. Although the function of Nck has been studied
in various organisms, the biological function of NCK-1 in C. elegans
has only been recently explored [12]. Furthermore, what
molecules interact with the C. elegans NCK-1 is still unknown.
The WASP protein family (WASP and N-WASP) are scaffolds
that integrate multiple signaling pathways, leading to the
formation of short branched actin filaments through the activation
of the Arp2/3 complex [13]. The C. elegans N-WASP homolog,
WSP-1, functions in neuronal cell migration and axon guidance
[14,15]. However, a connection between WSP-1 and a guidance
receptor has not yet been established.
The Ena/VASP proteins are involved in actin-dependent
movements including neuronal migration and axon guidance,
and are known for their role in promoting filopodia formation
[16]. In C. elegans, the Ena/VASP homolog UNC-34 is required
for proper neuronal cell migration, axon guidance and filopodia
formation [14,17,18,19,20]. Previous work has shown that Ena/
VASP proteins are versatile in their developmental roles and
function in both repulsive and attractive cues. For example Ena/
VASP are effectors of receptors for repulsive cues such as SAX-3/
Robo, UNC-5/Netrin receptor and EphB4, but they can as also
act as effectors for attractive cues downstream of receptors such as
UNC-40/DCC [21,22,23,24,25].
The Arp2/3 complex is a conserved family of actin nucleators
and when activated results in the formation of an elaborate
network of branched actin filaments similar to those found in
lamellipodia [26,27]. In C. elegans, the Arp2/3 complex is required
for axon guidance, and the initiation of growth cone filopodia
downstream of an unidentified axon guidance signal [15,20].
In this paper, we describe some of the molecular events that
allow the VAB-1 Eph RTK to regulate actin dynamics for axon
guidance. We provide genetic and biochemical evidence to show
PLoS Genetics | www.plosgenetics.org 1 February 2012 | Volume 8 | Issue 2 | e1002513that VAB-1 signals through NCK-1 and WSP-1/N-WASP, and
negatively regulates UNC-34/Ena. We propose a model for PLM
(Posterior lateral microtubule) axon termination whereby the
VAB-1 Eph RTK is able to prevent axon extension by inhibiting
growth cone filopodia formation. This is accomplished by
negatively regulating the activity of the filopodia elongator
UNC-34/Ena, and simultaneously activating Arp2/3 through a
VAB-1/NCK-1/WSP-1 complex.
Results
VAB-1 signals through the C. elegans NCK-1 SH3/SH2
adaptor protein
To identify VAB-1 Eph RTK effectors, we utilized transgenic
animals carrying mec-4::myr-vab-1 (quIs5) which encodes a consti-
tutively active VAB-1 tyrosine kinase (myristoylated-VAB-1
termed MYR-VAB-1) in the mechanosensory neurons [6]. In
wild-type young adults, PLM neuron cell bodies are located in the
tail region and have axons that stop at the centre of the animal
(Figure 1A). We previously showed that myr-vab-1 caused neuronal
defects in the mechanosensory neurons, in particular the
premature termination of PLM axons (Figure 1A, 1B) [6]. Since
the MYR-VAB-1 behaves as a constitutively active VAB-1 RTK,
we reasoned that mutations in effectors of the VAB-1 signal may
suppress the neuronal defects. We used a candidate gene approach
to examine genes with known roles in axon guidance and tested
whether loss-of-function mutations could suppress the myr-vab-1
PLM premature termination phenotype. We identified nck-1 as a
candidate effector of VAB-1 Eph RTK signaling. The nck-1(ok694)
mutation partially suppressed the PLM axon premature termina-
tion (Figure 1B), indicating that other effectors are involved in the
MYR-VAB-1 signaling. The C. elegans genome encodes for only
one nck-1 adaptor protein, and is most similar to the human Nck2
and Drosophila DOCK [12]. NCK-1 has all the domain features of
the NCK adaptor proteins, including three SH3 domains followed
by a single SH2 domain. We previously reported that the deletion
allele nck-1(ok694) is predicted to be a null allele, thus all of our
genetic work was carried out using the ok694 allele [12].
If NCK-1 is an effector of VAB-1 signaling then we would
expect the nck-1 loss-of-function mutation to have a phenotype
similar to that of the vab-1 loss-of-function. Indeed, previous work
showed that both vab-1 and nck-1 mutants have similar neuronal
defects, including an overextension in PLM axons (Figure 1C)
[6,7,12]. To further confirm that nck-1 and vab-1 are in the same
pathway in the PLM neurons, we analyzed the effect of the double
mutation on the PLM axons. The vab-1; nck-1 double mutation did
not enhance the PLM over extension phenotype (Figure 1C),
indicating that NCK-1 and the VAB-1 Eph receptor function in
the same pathway to guide the PLM axons.
To determine if the PLM defects observed in vab-1 and nck-1
animals were present at an earlier stage, we examined the PLMs of
the first larval stage (L1) (see Methods). Wild-type L1s had PLM
axons that were 103–114 mm long, and terminated at a region
anterior to the tip of the ALM cell body (93%) and is consistent
with previous reports for L1 PLM lengths [28] (Figure 2A). Both
vab-1 and nck-1 animals had PLM axons that significantly
overgrew beyond the wild-type termination region (Figure 2A,
2B). This indicates that VAB-1 and NCK-1 are required at an
early stage to prevent PLM axons from overgrowing beyond their
normal termination region. We also showed that 96% of L1 myr-
vab-1 transgenic animals had PLM axons that were undergrown
when compared to wild-type (Figure 2A, 2C). The PLM
undergrowth defects caused by MYR-VAB-1 were significantly
reduced by nck-1(ok694) (57%) (Figure 2C). These results are
consistent with our analysis carried out in early adults, and further
confirm that NCK-1 is an effector of VAB-1 signaling in PLM
axon guidance.
NCK-1 is expressed in the nervous system and
co-localizes with VAB-1
We previously showed that NCK-1 is expressed in various
tissues including the nervous system [12]. In addition, like VAB-1,
NCK-1 can function cell autonomously in the mechanosensory
neurons for PLM axon guidance [6,12]. If NCK-1 and VAB-1
function in the same pathway during neuronal development,
then they should be localized in the same cells. Indeed, NCK-1
and VAB-1 were co-localized in some of the neurons, con-
sistent with the role of NCK-1 as an effector of VAB-1 (Figure 3A,
3B). However, the expression pattern of VAB-1 and NCK-1
did not overlap exactly, suggesting that both NCK-1 and
VAB-1 have independent roles during development (Figure 3A).
Expression of NCK-1-GFP and activated VAB-1 (MYR-VAB-1)
in the mechanosensory neurons showed that NCK-1 did co-
localize with activated VAB-1 in the PLM axon and cell body
(Figure 3B).
The NCK-1 SH2 domain interacts with VAB-1
phosphotyrosine Y673
In a parallel approach we used yeast two-hybrid screens to
identify effectors of VAB-1/Eph RTK signaling and identified the
full length NCK-1 as a binding partner of the VAB-1 intracellular
kinase region. Yeast two-hybrid analysis showed that the NCK-1
SH2 domain is sufficient to bind VAB-1 and that VAB-1 tyrosine
Y673 is crucial for the interaction with the NCK-1 SH2 domain
(Figure 4A).
To further confirm the NCK-1/VAB-1 interaction we used
GST-pull down assays. Deletion analyses confirmed that the SH2
domain is necessary and sufficient to bind VAB-1 (Figure 4B).
Furthermore, the NCK-1 interaction required an active tyrosine
VAB-1 kinase since the NCK-1 SH2 domain did not bind a kinase
inactive version of VAB-1 (G912E) (Figure 4C, 4D). Since SH2
Author Summary
The correct wiring of the nervous system depends on the
ability of axons to properly interpret extracellular cues that
guide them to their targets. The Eph receptor tyrosine
kinases (RTKs) have roles in guiding axons, but their
signaling pathways are not completely understood. In this
study, we used the nematode Caenorhabditis elegans to
study how the VAB-1 Eph RTK regulates the growth cone
structure for axon guidance. Genetic and molecular data
show that VAB-1 regulates the conserved molecules NCK-
1, WSP-1/N-WASP, and UNC-34/Ena. Our study provides a
model of how the VAB-1 Eph RTK modulates the growth
cone structure to inhibit axonal outgrowth. We show that
activated VAB-1 can inhibit an NCK-1/UNC-34 interaction
by binding to the NCK-1 SH2 domain. We also show that
NCK-1 and WSP-1 can physically interact and that VAB-1/
NCK-1 and WSP-1 form a complex in vitro. We suggest that
the VAB-1 Eph RTK can contribute to the termination of
axon outgrowth by two methods: 1) The VAB-1/NCK-1/
WSP-1 complex activates ARP-2/3 to change the actin
growth cone dynamics to that of a branched structure
thus reducing the number of filopodia, and 2) VAB-1
inhibits axon extension by inhibiting UNC-34/Ena’s func-
tion in actin polymerization.
Eph Activates NCK and WASP, and Inhibits Ena/VASP
PLoS Genetics | www.plosgenetics.org 2 February 2012 | Volume 8 | Issue 2 | e1002513Figure 1. PLM defects in various backgrounds and their genetic interactions. (A) Young adults expressing mec-4::gfp(zdIs5). Anterior is to
the left. Solid arrow points to where the PLM axon ends. A line diagram that corresponds to the morphology of the neuron is shown below. In wild-
type animals (top gfp panel) the PLM axons terminate at the middle (vulva region triangle). MYR-VAB-1 (middle gfp panel) causes PLM axons to
terminate before reaching their target. wsp-1(gm324) animals (bottom gfp panel) have PLM axons that overshoot past the vulva (triangle) and ALM
neuron (dashed arrow). (B) The nck-1(ok694) and wsp-1(gm324) alleles significantly reduced the early termination defects caused by MYR-VAB-1. Over
expressing unc-34 in the PLMs also reduced the MYR-VAB-1 termination defect. (C) vab-1, nck-1 and wsp-1 animals have PLM overextension defects.
Reducing the levels of UNC-34 via tissue specific RNAi suppressed the PLM overextension defects of vab-1(dx31) and wsp-1(gm324). (D) unc-34(e566)
loss-of-function and tissue specific unc-34 RNAi exhibit PLM axon termination. Over expression of NCK-1 in the mechanosensory neurons (mec-4::nck-
1) caused low levels of the PLM early termination defects, but synergized in the unc-34(e566) background. Activating the Arp2/3 complex via the WSP-
1 VCA domain (mec-4::vca) caused PLM axon termination defects. Error bars indicated the SEM, and significant differences between some of the
strains were compared (using student’s t-test), *P,0.05; **P,0.01; ***P,0.001; n.s.=not statistically significant. ‘N’ refers to the number of axons
scored.
doi:10.1371/journal.pgen.1002513.g001
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PLoS Genetics | www.plosgenetics.org 3 February 2012 | Volume 8 | Issue 2 | e1002513Figure 2. PLM over extension and early termination defects are observed at the L1 larval stage. (A) L1 larva expressing mec-4;;gfp (zdIs5).
Anterior is to the left. Solid arrow points to where the PLM axon ends. The ALM cell body and the anterior end of the PLM axon are shown in each
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how specific the NCK-1 SH2 domain is for VAB-1. We found that
four other SH2 domains (MIG-10, SEM-5, ABL-1, VAV-1) were
unable to bind VAB-1 (Figure 4E). In summary, NCK-1 interacts
with VAB-1 in a kinase dependent manner, the interaction is
mediated via the NCK-1 SH2 domain and the VAB-1 Y673
juxtamembrane tyrosine, and VAB-1 has high specificity for the
NCK-1 SH2 domain.
panel. A line diagram corresponding to the morphology of the neuron is shown to the right. The dashed lines in all panels represent the wild-type
PLM termination boundary. In wild-type L1s (top gfp panel) the PLM axons are between 103 and 114 mm in length, and terminate at a region anterior
to the tip of the ALM cell body. vab-1(dx31) mutants (middle gfp panel) have L1 PLM axons that overgrow beyond the normal wild-type range.
Animals that over express VAB-1 (MYR-VAB-1) (bottom gfp panel) have L1 PLM axons that are significantly shorter (undergrowth) than wild-type. (B)
vab-1, nck-1 and wsp-1 L1s have PLM axons that are overgrown beyond the normal range. (C) The nck-1(ok694) and wsp-1(gm324) alleles significantly
reduced the undergrowth defects caused by MYR-VAB-1. Error bars indicated the SEM, and significant differences between some of the strains were
compared (using student’s t-test), **P,0.01; ***P,0.001. ‘N’ refers to the number of axons scored.
doi:10.1371/journal.pgen.1002513.g002
Figure 3. NCK-1 co-localizes with VAB-1. Anterior is to the left in all panels. (A–B) NCK-1 is in Green and VAB-1 is Red. (A) NCK-1 and VAB-1 co-
localized in some cells. Arrow head points to cells where both NCK-1 and VAB-1 are co-localized, and the arrow points to cells that only express NCK-
1. The translational nck-1::gfp transgene encodes the NCK-1A isoform and was detected using anti-GFP antibodies. Endogenous VAB-1 was detected
using anti-VAB-1 antibodies (see experimental procedures). (B) NCK-1 and VAB-1 co-localized in the cell body and axon of the PLM neurons. nck-
1A::gfp and myr-vab-1 were expressed in the PLM under the mec-4 promoter, and were detected using anti-GFP and anti-VAB-1 antibodies
respectively.
doi:10.1371/journal.pgen.1002513.g003
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PLoS Genetics | www.plosgenetics.org 5 February 2012 | Volume 8 | Issue 2 | e1002513Figure 4. NCK-1 physically interacts with VAB-1 and UNC-34. (A) The NCK-1 SH2 domain binds to the Y673 of VAB-1. Yeast-two hybrid assays
shows that the NCK-1 SH2 domain (Prey) can bind wild-type (WT) VAB-1 (669 aa–985 aa), but fails to interact when VAB-1 Y673 is changed to
glutamic acid (Y673E). (B–C) GST pull-down assays. L=Load; U=unbound fraction; B=bound fraction. (B) Different NCK-1 domains fused to GST show
that the SH2 domain is required for VAB-1 binding. The three SH3 domains alone do not bind VAB-1. (C) Bacterial expressed MBP-VAB-1 (intracellular
region) has tyrosine kinase activity and shows autophosphorylation. The point mutation G912E in the VAB-1 kinase domain abolishes the VAB-1
kinase activity. The asterisks indicate break down products during purification. Phosphotyrosine was detected using anti-phosphotyrosine antibodies
(4G10). The blot was stained with Ponceau S to show equal protein loading (below). (D) The binding of SH2 domain of NCK-1 to VAB-1 is kinase
dependent. The kinase inactive VAB-1(G912E) failed to interact with the SH2 domain of NCK-1. (E) The NCK-1 SH2 domain shows high specificity for
VAB-1. Yeast-two hybrid assays of other SH2 domains failed to interact with VAB-1. (F–G) GST-NCK-1 pull-down assays with MBP-UNC-34. (F) UNC-34
binds to NCK-1, both the proline rich (PRO) and EVH2 domains are required to bind NCK-1 (not shown). (G) Different GST-NCK-1 domains show that all
SH3 domains can independently interact with full length UNC-34. The asterisks marks the correct protein fragment expected, and all other fragments
below the marked are break down products. The dashed lines in E and F indicate a cropped region from the same blot.
doi:10.1371/journal.pgen.1002513.g004
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NCK-1
How does VAB-1 cause the PLM to stop once the VAB-1 Eph
RTK is activated and adaptor proteins such as NCK-1 bind the
receptor? A previous report indicated that Ena/VASP was
required for repulsion caused by EphB4 signaling in fibroblasts,
but it was unclear how the signal was conveyed [24]. The Ena/
VASP family are composed of an N-terminal EVH1 domain, a
central PRO region and a C-terminal Ena/VASP homology II
domain (EVH2) [16]. We asked if NCK-1 could be the link
between the Eph RTK and Ena/VASP. We first tested if NCK-1
and UNC-34 can directly interact. In vitro binding assays with
bacterially expressed NCK-1 and UNC-34 confirmed that both
proteins do indeed physically interact (Figure 4F, 4G). Further-
more, we found that the PRO-EVH2 domains are required
together to bind NCK-1 (data not shown). We also showed that all
three NCK-1 SH3 domains were able to bind UNC-34
(Figure 4G).
While nck-1 and vab-1 animals have overextended PLM axons,
unc-34 animals have the opposite phenotype and have PLM axons
that terminate prematurely (Figure 1D, Figure 2C). This suggests
that UNC-34 is involved in PLM axon extension, and reflects a
known role of Ena/VASP in actin filament formation and
elongation [16,29]. To understand the genetic nature of the
interaction between nck-1 and unc-34, we analyzed the nck-
1(ok694); unc-34(e566) double and found that nck-1 partially
suppressed the unc-34 PLM termination defect, while unc-34 did
not suppress the nck-1 overgrowth (Figure 1D, and data not
shown). This suggests that, in PLM axon outgrowth, unc-34 may
negatively regulate nck-1. To provide further evidence for this
genetic interaction we over expressed NCK-1 (mec-4::nck-1) in the
PLM neurons of unc-34(e566) animals and this resulted in a
synergistic enhancement of the unc-34 PLM termination pheno-
type (Figure 1D). Although we cannot conclusively rule out that
nck-1 inhibits unc-34, overall, our results suggest that UNC-34 can
inhibit the function of NCK-1 and may do so by physically
binding to it.
VAB-1 disrupts the NCK-1/UNC-34 interaction and
negatively regulates UNC-34
Since UNC-34 and NCK-1 physically interact, we wanted to
examine whether VAB-1, NCK-1 and UNC-34 could form a
complex in vitro. Surprisingly, although UNC-34 can bind strongly
to NCK-1, the introduction of VAB-1 abolished the binding
between UNC-34 and NCK-1 (Figure 5A Lane 4, 5). This result
suggests that VAB-1 might be inducing its effect at the growth
cone membrane by relieving the inhibition of NCK-1 that is
caused by UNC-34. To provide in vivo support of this we over
expressed UNC-34 in the mechanosensory neurons (mec-4::unc-34)
and it significantly reduced the MYR-VAB-1 PLM premature
termination phenotype (Figure 1B).
To gain more insight into the interaction between VAB-1 and
UNC-34, we sought to analyze the effect of the vab-1;unc-34 double
on PLM axons. We found that the vab-1;unc-34 double mutant is
synthetic lethal (data not shown), so we used a mechanosensory
specific unc-34 RNAi approach (see experimental procedures). The
unc-34(RNAi) strain had PLM termination defects that were similar
to unc-34(e566) (Figure 1D). Analysis of the vab-1;unc-34(RNAi)
double showed that reducing the levels of unc-34 can rescue the
PLM overextension defects seen in vab-1(dx31) (Figure 1C), which
is consistent with vab-1 inhibiting unc-34 function. Since the genetic
data suggested that vab-1 negatively regulates unc-34,w e
questioned if the activation of VAB-1 could affect the expression
and/or localization of UNC-34. Induction of MYR-VAB-1 via
heat shock promoter did not change the localization of UNC-34,
but instead resulted in the reduction of UNC-34::GFP levels
compared to wild-type animals (Figure 5B). To test whether VAB-
1’s negative regulation can function cell autonomously in the
PLMs, we expressed UNC-34::GFP only in the mechanosensory
neurons (via mec-4 promoter) and it is expressed at high levels.
When we introduce constitutively active VAB-1 only in the touch
neurons (mec-4::myr-vab-1) it reduced the UNC-34::GFP levels
significantly (Figure 5C).
In summary, our binding assays and genetic analyses show that
VAB-1 activation results in binding NCK-1 which in turn blocks
the UNC-34 binding to NCK-1, freeing NCK-1 from the negative
influence of UNC-34 and in addition VAB-1 negatively regulates
UNC-34 protein levels.
WSP-1 is an effector for VAB-1/NCK-1
Since mammalian Nck is known to physically bind and activate
N-WASP to regulate actin filaments through the Arp2/3 complex
[8,30,31], we questioned whether VAB-1 is linked to the
cytoskeleton through WSP-1/N-WASP. If WSP-1 acts down-
stream of VAB-1, then the wsp-1 mutants should suppress the
PLM termination defect caused by MYR-VAB-1. Two wsp-1
alleles are predicted to affect the WSP-1 protein. The wsp-
1(tm2299) is not well characterized, but is homozygous lethal and
is predicted to be a null allele. The embryonic lethality is due to
wsp-1 pleiotropy as WSP-1 is also required for cytokinesis during
embryogenesis [14]. The wsp-1(gm324) allele is a well character-
ized deletion that removes exons 2 and 3, furthermore, no WSP-1
protein nor mRNA can be detected, therefore wsp-1(gm324) is a
strong loss-of-function allele [14]. wsp-1(gm324) displays some
embryonic and larval lethality but can be maintained as a
homozygote [14,15,32]. We chose to use the wsp-1(gm324) allele as
it allowed us to bypass the embryonic lethality associated with the
wsp-1 null allele. We found that wsp-1(gm324) could significantly
suppress the MYR-VAB-1 PLM termination defect in young
adults and L1s (Figure 1B, Figure 2C).
If WSP-1 is an effector of VAB-1 signaling then we would
expect to see neuronal defects similar to vab-1 animals. It was
previously reported that the wsp-1(gm324) had weak axon
guidance defects, such as in the PDE and VD/DD neurons
[15]. We report here that approximately 50% of wsp-1(gm324)
animals have overextended PLM defects in young adults, and 42%
PLM axon overgrowth in L1s (Figure 1C, Figure 2B). Since the
wsp-1 PLM overextension frequency is much greater than vab-1
(Figure 1C), it implies that WSP-1 also functions independent of
VAB-1 for PLM axon guidance. We also found that the vab-
1(dx31);wsp-1(gm324) double mutants are synthetic lethal (data not
shown), which is consistent with WSP-1 functioning in parallel
pathways with VAB-1.
The presence of WSP-1 in the VAB-1 signaling pathway
suggests the possibility that the PLM termination phenotype
caused by MYR-VAB-1 could be due to the activation of the
Arp2/3 complex. WSP-1, like its mammalian counterpart, is
composed of an N-terminal Ena/VASP homology I domain
(EVH1; also known as WASP-homology-1 domain (WH1)), a
central section containing a basic region (BR), a GTPase bind-
ing domain (GBD) and a proline-rich region (PRO), and a
C-terminal with two verprolin homology domains (V; also known
as WH2), a cofilin homology domain (C) and an acidic domain
(A) [13,14,32] collectively known as the VCA region. The
C-terminal VCA regions of both WSP-1 and N-WASP have
been shown to be sufficient for activating the Arp2/3 complex
in vitro [32,33]. We utilized the C-terminal VCA region of WSP-1
Eph Activates NCK and WASP, and Inhibits Ena/VASP
PLoS Genetics | www.plosgenetics.org 7 February 2012 | Volume 8 | Issue 2 | e1002513to selectively activate the Arp2/3 complex in the mechanosensory
neurons (mec-4::wsp-1
vca). The WSP-1
VCA caused PLM premature
termination defects that were very similar to MYR-VAB-1
(Figure 1D).
The activation of high levels of the Arp2/3 complex produces
extensive short branched actin networks that prevent the
formation of filopodia, and hence can inhibit axon extension
[34,35]. Ena/VASP, on the other hand, promotes axon extension
through filopodia formation and elongation [16,17,20,29]. Thus,
activation of Arp2/3 complex and UNC-34/Ena have opposite
roles in the axon growth cone, and perhaps Arp2/3 complex
activation can antagonize the function of UNC-34/Ena. Since
WSP-1/N-WASP is an activator of the Arp2/3 complex, we
wanted to test genetically if wsp-1 can antagonize unc-34 function.
Due to the synthetic lethality of wsp-1; unc-34 double mutants
[14,36], we analyzed the PLM axons in wsp-1; unc-34(RNAi)
animals. Tissue specific unc-34 RNAi resulted in the partial
suppression of PLM overextension defects caused by wsp-1(gm324)
(Figure 1C), consistent with WSP-1/Arp2/3 activity antagonizing
UNC-34 function.
In summary, we show that WSP-1 functions in PLM axon
termination, through various signaling pathways, including the
VAB-1 Eph RTK. Our results suggest that MYR-VAB-1 is
exerting its effect by activating the Arp2/3 complex through WSP-
1. We also suggest that WSP-1 can antagonize UNC-34 function
by activating the Arp2/3 complex.
VAB-1 enables WSP-1 to outcompete UNC-34 for NCK-1
binding
We used in vitro binding assays to ask whether VAB-1, NCK-1
and WSP-1 could form a complex. WSP-1 was able to bind NCK-
1 (Figure 6A, Lane 6), but not VAB-1 (Figure 6A, Lane 5).
However, WSP-1 was able to pull down VAB-1 in the presence of
NCK-1, indicating that a VAB-1/NCK-1/WSP-1 complex can
occur (Figure 6A, Lane 7).
Since NCK-1 is able to bind both UNC-34 and WSP-1, we
wanted to determine whether all three molecules can form a
complex, or do UNC-34 and WSP-1 compete for NCK-1 binding.
We first confirmed that WSP-1 was unable to bind UNC-34
Figure 5. VAB-1 inhibits the UNC-34/NCK-1 complex and negatively regulates UNC-34 protein levels. (A) NCK-1 (GST) pull-down
experiments. NCK-1 can pull-down UNC-34 (lane 3). Adding VAB-1 (either co-expressed (high VAB-1), lane 4, or mixing (low VAB-1), lane 5) inhibits the
interaction between NCK-1 and UNC-34. VAB-1, NCK-1 and GST protein levels shown below, the dashed line indicates a cropped region from the blot.
Tagged protein fusions used: GST-NCK-1, HIS-VAB-1, and MBP-UNC-34. Proteins were detected with antibodies to GST, MBP or VAB-1. (B) Inducing
hyperactive MYR-VAB-1 (quIs16) via a heat shock promoter reduces the levels of UNC-34::GFP. unc-34::gfp transgenic animals had a GFP relative mean
intensity of 160.07 (N=12) under heat shock conditions, while hs:myr-vab-1;unc-34::gfp animals had a GFP relative mean intensity of 0.56604
(p,0.01; student’s t-test; N=16) under the same conditions. All panels show UNC-34::GFP image of the CAN neuron. ‘N’ refers to the number of
animals. (C) Images show PLM cells expressing mec-4::unc-34::gfp. In wild-type animals (left panel), the PLM shows high levels of UNC-34 expression
and in contrast, the UNC-34 intensity is reduced in mry-vab-1 transgenic animals (right panel). Images were taken at identical exposure settings;
dashed line outlines the PLM cell body; ‘N’=number of animals; scale bar equals 2 mm.
doi:10.1371/journal.pgen.1002513.g005
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1, the presence of UNC-34 resulted in a 70% reduction of the
NCK-1/WSP-1 complex (Figure 6B, Lane 8). This shows that
UNC-34 can effectively compete with WSP-1 for NCK-1 binding.
Furthermore we could not detect NCK-1/UNC-34/WSP-1 in a
complex (Figure 6B, Lane 8). Interestingly, adding VAB-1 to the
binding interaction increased the level of NCK-1 binding to WSP-
1, indicating that VAB-1 eliminated UNC-34’s ability to compete
for NCK-1 binding (Figure 6B, Lane 9). In summary, our binding
assays show that VAB-1, NCK-1 and WSP-1 form a complex, that
UNC-34 competes with WSP-1 for NCK-1 binding, and that
VAB-1 enables WSP-1 to outcompete UNC-34 for binding to
NCK-1.
VAB-1 signaling inhibits filopodia on the PLM growth
cone
The VAB-1 RTK effectors NCK-1 and WSP-1 are known actin
regulators and therefore implicate VAB-1 signaling in regulating
actin cytoskeleton for axon guidance. To confirm this, we
monitored the PLM growth cone of wild-type and myr-vab-1
transgenic animals at the time of hatching. In wild-type animals,
most of the PLM growth cones exhibited dynamic changes and
had many filopodia protrusions (70%; N=20 movies) (Figure 7A,
Video S1). Transgenic myr-vab-1 animals, on the other hand, had
growth cones that were less dynamic and were usually void of
filopodia like structures with only 25% (N=16 movies) showing
some filopodia structures (Figure 7B, Video S2). Since our
molecular and genetic data suggest that VAB-1 inhibits UNC-
34/Ena function we also observed the growth cones of unc-
34(e566) animals. We found that unc-34(e566) mutants, like myr-
vab-1 animals, had growth cones void of filopodia structures with
only 25% displaying filopodia structures (N=12 movies; not
shown). Our results show that activated VAB-1 can affect the PLM
growth cone morphology by inhibiting filopodia formation.
Discussion
We previously reported a functional role for VAB-1 as a receptor
for a repellent or stop signal in PLM axon guidance [6]. Here we
describe some of the molecular events involved in VAB-1 signaling
that allow the regulation of actin dynamics for PLM axon guidance.
Ourgenetic and invitro interactionanalysisidentifiedNCK-1,WSP-
1 and UNC-34 as molecules regulated by VAB-1 Eph RTK
signaling. Our data supports a model in which VAB-1 suppresses
axonextensionbynegativelyregulatingUNC-34,andactivating the
Arp2/3 complex through a VAB-1/NCK-1/WSP-1 complex.
Furthermore, using time-lapse analysis we show that activation of
VAB-1 inhibits filopodia formation in the PLM growth cone.
NCK-1 and Eph RTK signaling
Our results show that the C. elegans NCK-1 adaptor protein is an
effector of the VAB-1 RTK signal in vivo. Several lines of evidence
Figure 6. VAB-1, NCK-1, and WSP-1 interact in a complex. (A–B) WSP-1 (MBP) pull-down experiments. (A) VAB-1/NCK-1/WSP-1 can form a
complex. WSP-1 does not pull-down VAB-1 (lane 5), WSP-1 can pull down NCK-1 (lane 6), and WSP-1 can pull down VAB-1 only in the presence of
NCK-1 (compare lane 5 and lane 7), (B) VAB-1 enables WSP-1 to outcompete UNC-34 for NCK-1 binding. WSP-1 does not pull down UNC-34 (lane 6).
WSP- 1 pulls down NCK-1 (lane 7, NCK-1 relative intensity 1.0) and adding UNC-34 reduces the level of interaction between NCK-1 and WSP-1 (lane 8
(asterisks), NCK-1 relative intensity 0.360.2). UNC-34 is not detected in lane 8 suggesting that NCK-1/UNC-34/WSP-1 do not form a complex. Adding
VAB-1 prevents UNC-34 from inhibiting the interaction between NCK-1 and WSP-1 (lane 9, NCK-1 relative intensity 1.360.1). Protein levels shown
below, dashed line indicates a cropped region from the blot. Tagged protein fusions used: MBP-WSP-1, GST-NCK-1, HIS-VAB-1 and GST-UNC-34.
Proteins were detected with antibodies to GST, MBP or VAB-1.
doi:10.1371/journal.pgen.1002513.g006
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PLoS Genetics | www.plosgenetics.org 9 February 2012 | Volume 8 | Issue 2 | e1002513Figure 7. VAB-1 activation affects PLM growth cone dynamics. (A–B) Series of time-lapse images of newly hatched L1 PLM growth cones as
they migrate anteriorly. Scale bar represents 2 mm. (A) Wild-type PLM growth cones exhibit dynamic changes and display multiple filopodia
protrusions. (B) Transgenic myr-vab-1 animals have PLM growth cones that are less dynamic and mostly void of any protrusions. (C) A model of how
VAB-1 induces its termination effect during PLM axon guidance. (Left) In the absence of VAB-1 activation, UNC-34/Ena promotes axon extension
through the polymerization of actin filaments and forming filopodia. UNC-34/Ena also physically binds to and inhibits NCK-1’s role with WSP-1. It is
possible that the UNC-34/NCK-1 heterodimer could work together in promoting actin polymerization downstream of other receptors and is indicated
by question marks (?). (Right) Genetic and molecular data suggest that VAB-1 inhibits UNC-34 function. Activation of VAB-1 contributes to stopping
axon outgrowth by binding to the NCK-1 SH2 domains, which disrupts the interaction between NCK-1 and UNC-34. VAB-1 over expression can reduce
UNC-34 protein levels thereby preventing further actin filament polymerization. Furthermore, VAB-1, NCK-1 and WSP-1 can now form a complex and
induce high levels of Arp2/3 activation to form an extensive network of short, branched actin filaments. The combination of inhibiting actin filament
polymerization and increasing short, branched networks stop the formation of new filopodia. The net result is the termination of axon extension in
response to VAB-1 signaling.
doi:10.1371/journal.pgen.1002513.g007
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guidance. First, nck-1 and vab-1 animals have similar neuronal
defects. Second, NCK-1 and VAB-1 physically interact and co-
localize in similar neuronal cells and axons. Finally, the nck-1 loss-
of-function suppresses the defects caused by the constitutively
active VAB-1. We found that NCK-1 binds the VAB-1
juxtamembrane tyrosine Y673 (YEDP) via its SH2 domain in a
VAB-1 kinase dependent manner. This is consistent with the
published binding specificity of the Nck SH2 domain, as well as
reports of Nck1 binding to the second juxtamembrane tyrosine
residue (YEDP) in EphA3 (Y602) and EphA2 (Y594) [37,38,39].
Interestingly, Nck adaptors have been reported to function
downstream of Eph RTKs but it appears that the activated EphA
RTKs are direct targets of Nck adaptors [38,39,40,41], whereas
Nck may indirectly interact with EphBs [11,42,43]. Considering
that the intracellular region of VAB-1 is more similar to EphA
receptors [4], our results in C. elegans provides relevant insight into
how mammalian EphA receptors could regulate the actin
cytoskeleton for axon guidance.
Ena/VASP in Eph RTK signaling
The Ena/VASP protein family is required in processes that
involve dynamic actin remodeling such as platelet shape change,
axon guidance and Jurkat T cell polarization [44]. The ability of
Ena/VASP proteins to remodel actin stems from their ability to
polymerize actin, which is required for filopodia formation and
elongation [16,45,46]. In C. elegans, UNC-34/Ena functions in
neuronal cell migration, axon guidance and epithelial filopodia
formation [14,18,19,20]. Our results further confirm the role of
UNC-34 in axon extension, because we show that the unc-34(e566)
PLM axons terminated prematurely. The cause of early
termination is likely due to a reduction of filopodia elongation in
the growth cone, resulting in the persistence of more densely
branched filaments that can slow axon migration. This is
supported by the finding that unc-34 mutants have fewer filopodia
structures on growth cones, and a reduced rate of growth cone
migration [20] (this work and our unpublished observations). In
addition, mammalian studies show that depletion of Ena/VASP
generates shorter and more densely branched filaments [47].
We propose that VAB-1 negatively regulates UNC-34 for PLM
termination. This is supported by our observations that: 1) the loss-
of-function unc-34 resulted in PLM axon defects similar to the
hyperactive MYR-VAB-1; 2) over expressing UNC-34 in the PLM
partially suppressed the MYR-VAB-1 phenotype; 3) tissue specific
unc-34 RNAi suppressed the vab-1 PLM overextension defects; and
4) over expressing VAB-1 reduced the UNC-34 protein levels.
Although we do not know the mechanism of the reduction of the
UNC-34 protein levels displayed in the hyperactive VAB-1, it is
possible that UNC-34, when removed from its adaptor NCK-1, is
more prone to degradation. In this case NCK-1 may play a dual
role and may also promote UNC-34 function as well. It is also
likely VAB-1 signaling could affect the unc-34 transcriptional level.
Future experiments should resolve how VAB-1 regulates UNC-34
protein levels.
Our finding that VAB-1 negatively regulates UNC-34/Ena is
different from a previous report that shows mammalian EphB4 as
an activator of Ena/VASP [24]. In fibroblast cells, the EphB4
receptor is thought to activate Ena/VASP to destabilize
lamellipodia during cell repulsion and likely does so by promoting
elongated actin filaments rather than a branched actin filament
network. Although the Eph receptor signal transduction to Ena or
UNC-34 is opposite (activates vs. inhibits) the role for UNC-34/
Ena is conserved, because in both cases UNC-34 or Ena/VASP
promotes actin filament elongation.
A VAB-1/NCK-1/WSP-1 complex regulates the actin
cytoskeleton
Our results provide evidence that VAB-1/Eph RTK can
regulate the actin cytoskeleton through its interaction with NCK-1
and WSP-1. This is based on our observation that vab-1, nck-1 and
wsp-1 mutants share the same phenotype of PLM axon
overextension, that both nck-1 and wsp-1 were able to partially
suppress the MYR-VAB-1 PLM termination defect, that VAB-1,
NCK-1 and WSP-1 are able to form a complex in vitro, and that
the activation of the Arp2/3 complex via the WSP-1 VCA domain
resulted in PLM termination defects similar to MYR-VAB-1. The
role of N-WASP as a negative regulator of axon elongation has
been shown by two separate reports, where the reduction of N-
WASP resulted in the enhancement of axon elongation [48,49].
This phenotype is reminiscent of the PLM overextension defects
we observed in wsp-1 animals. There have been conflicting reports
on the role of the Arp2/3 complex in axon elongation, where some
reports suggest that the Arp2/3 complex acts as a negative
regulator of axon elongation [34,49], while other reports show that
the Arp2/3 complex is required for axon elongation [20,50]. A
paper by Ideses et al. (2008) provided a potential resolution to this
paradox by looking at the characteristics of actin assembly in the
presence of variable amounts of Arp2/3 complex in vitro [35]. It is
proposed that high levels of the Arp2/3 complex prevent the
formation of filopodia bundles by promoting the extensive
branching networks of actin with short tips. On the other hand,
at low concentrations of Arp2/3 the actin filaments have longer
tips and are further apart making it easier to form filopodia
bundles [35]. Therefore, it would be expected that the complete
elimination of Arp2/3 would prevent any neurite elongation.
Similarly, the excessive activation of Arp2/3 would also prevent
neurite elongation due to the increased levels of short, branched
networks of actin filaments. In the C. elegans epithelial cells unc-34
and wsp-1 function redundantly for epithelial cell migrations [14].
However our results in PLM neurons suggest that WSP-1 and
UNC-34 have opposite roles. Why the apparent paradox? This is
reminiscent of what has been observed for Ena/VASP proteins
where some reports suggest Ena/VASP promotes actin dependent
processes while others suggest Ena/VASP may inhibit actin
dependent processes [51]. While the growth cones on axons and
the leading edge of epithelial cells both require actin for
movement, they might not be identical in the way the cell moves
forward. Proteins such as Ena/VASP, N-WASP, and Arp2/3
are thought to promote actin polymerization, however these
proteins also change the geometry of the actin filament network
in addition to promoting actin assembly. Therefore the overall
effects of such changes in the actin network may not be easy to
predict with respect to cell movement since various concentrations
of these actin regulators could lead to activation or inhibition of
filopodia. Since WSP-1/N-WASP is an activator of the Arp2/3
complex and different levels of Arp2/3 can elicit different
behaviors, WSP-1 may also have opposite effects depending on
its level of activity. In addition, while most of our results are based
on the PLM neurons it is very likely the roles of UNC-34 and
WSP-1 and how they are regulated will be different in other
neurons.
N-WASP has been shown to interact in a complex with the
mammalian EphB2, through the adaptor molecule intersectin
[52]. Furthermore, this complex of EphB2, intersectin and N-
WASP is required for dendritic spine formation, which consists
mainly of a meshwork of branched filaments caused by the
activation of the Arp2/3 complex [52]. C. elegans intersectin
(ITSN-1) is expressed in the nervous system, and it is enriched in
presynaptic regions and has roles in neurotransmission [53].
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with ITSN-1 to connect WSP-1. Our current work shows that the
VAB-1 Eph RTK can signal through WSP-1/N-WASP through a
different adaptor molecule, NCK-1, and we propose, like the
mammalian intersectin adaptor, this complex activates Arp2/3 to
promote branched actin.
Model for VAB-1 signaling in the PLM to stop axon
growth
We propose a model of how the proteins VAB-1, NCK-1,
UNC-34, WSP-1 and Arp2/3 function in axon growth cones for
extension and termination (Figure 7C). During PLM axon
outgrowth, the growth cone is stimulated by an attractive cue
that results in the accumulation of UNC-34/Ena at the growth
cone. The result is a net forward movement due to the role of
UNC-34/Ena in inhibiting actin capping proteins, and allowing
filopodia elongation by polymerizing F-actin at the leading edge.
In addition, UNC-34/Ena binds to the NCK-1 SH3 domains to
prevent it from interacting with WSP-1 and participating in a
signaling pathway(s) that would otherwise inhibit axon extension.
It is also possible that the UNC-34/NCK-1 heterodimer could
function together for actin polymerization or that NCK-1 binding
could stabilize the UNC-34 protein. In this case NCK-1 acts
positively with UNC-34. However, since unc-34 and nck-1 mutants
have opposite PLM axon phenotypes, it suggests that nck-1’s
role in axon outgrowth is more dispensable or redundant than its
role in axon termination. Once the VAB-1/Eph RTK receives the
signal to inhibit axon extension, VAB-1 is autophosphorylated and
provides a docking site (Y673) for NCK-1. The NCK-1-SH2
domain binds the activated VAB-1 receptor and this disrupts
the interaction between NCK-1 and UNC-34 to release the
inhibitory effect of UNC-34 on NCK-1. Through an unknown
mechanism, we also show that VAB-1 negatively regulates
the UNC-34/Ena protein levels. VAB-1/NCK-1 can now
recruit and activate WSP-1 and all three proteins form a complex,
which results in high levels of Arp2/3 activation, ultimately
leading to a branched meshwork of actin filaments. The combined
actions of VAB-1/Eph blocking UNC-34/Ena activity, while
activating Arp2/3 through NCK-1/WSP-1 contributes to the
molecular events required to stop the growth cone forward
movement.
Materials and Methods
Strains
All C. elegans strains were manipulated as described by Brenner
[54]. All alleles were isolated in the standard wild type Bristol
strain N2. All experiments were performed at 20uC unless
otherwise indicated. The following strains were used in this study:
N2 (var. Bristol) [54]; LGI: zdIs5[mec-4::gfp]; LGII: vab-1(dx31),
quIs5[mec-4::myr-vab-1]; LG IV: wsp-1(gm324),L GV :unc-34(e566);
LGX:, quIs6[unc-34::unc-34::gfp]; Unmapped: quIs16[hs::myr-vab-1]
[55]; Extrachromosomal arrays (this study): quEx131[mec-4::nck-
1A], quEx190[nck-1::nck-1A-gfp] [12], quEx215[mec-4::unc-34::gfp],
quEx281[mec-4::unc-34], quEx283 [mec-4::nck-1A::gfp] [12],
quEx321[mec-4::vca], quEx338[mec-4::unc-34 RNAi] (see tissue spe-
cific RNAi). Unless noted otherwise, all C. elegans strains were
obtained from the C. elegans Genetics Stock Center, (U. of
Minnesota).
Tissue-specific RNAi
To produce double stranded RNA (dsRNA) only in the
mechanosensory neurons, we constructed a cloning vector
(pIC659) with head to head Pmec-4 promoters on each side of a
Multiple Cloning Site (MCS) such that the sense and antisense
strands of an inserted cDNA would be transcribed. The mec-4::unc-
34 RNAi construct (pIC727) was created by cloning an unc-34
cDNA fragment (ATG start to the first SalI site, 388 bp) into the
pIC659 dual Pmec-4 RNAi cloning vector.
Molecular biology
The mec-4::nck-1A construct (pIC313) was previously described
in Mohamed and Chin-Sang (2011). The mec-4::unc-34 construct
(pIC624) was generated by amplifying unc-34 cDNA and sub-
cloning behind the mec-4 promoter. The same procedure was
used to make the mec-4::unc-34::gfp (pIC540) construct, but
unc-34 was fused to gfp amplified from pPD95.75. To create the
mec-4::vca construct (pIC673), the VCA region of WSP-1 (9108–
9606 of the wsp-1 gene; C07G1.4a in Wormbase) was amplified
from genomic DNA and cloned behind the mec-4 promoter. The
unc-34::unc-34::gfp translation reporter was generated by a PCR
fusion approach [56] using the following pieces: 1. A ,5k b
genomic region that includes 2 kb of 59UTR and the first
two exons of unc-34, 2. Exons 2–7 were amplified from RB2
cDNA library, and 3. a 868 bp GFP fragment amplified from
pPD95.75 (gift from Dr. Andrew Fire). The expression of the
UNC-34::GFP rescued the unc-34(e566) uncoordinated phenotype.
Details of plasmid/PCR constructs and primer sequences are
available upon request.
Transgenic animals
Transgenic animals were generated by germ-line transformation
as previously described [57]. The unc-34::unc-34::gfp translational
reporter was injected at a concentration of 20 ng/mL, and one of
the unc-34 rescuing lines (quEx61) was integrated to create quIs6.
The mec-4::unc-34 construct was injected at a concentration of
30 ng/mL into mec-4::gfp(zdIs5); mec-4::myr-vab-1(quIs5). The mec-
4::unc-34::gfp construct was injected at a concentration of 30 ng/
mL into N2. mec-4::unc-34RNAi, mec-4::vca and mec-4::nck-1 were
injected into mec-4::gfp(zdIs5) at 30 ng/mL. mec-4::nck-1(quEx131)
was later crossed into unc-34(e566), and mec-4::unc-34RNAi
(quEx338) was crossed into vab-1(dx31) and wsp-1(gm324).
Transgenic animals were identified by the co-injection marker
pRF4/rol-6 (30 ng/ml), or odr-1::rfp (30 ng/ml) [57]. At least two
independent lines were isolated and analyzed. The data shown are
from one representative line.
Antibodies
Mixed stage animals were fixed and stained as described in
Chin-Sang et al. (1999) [58]. Rabbit anti-VAB-1 antibodies
(antigen VAB-1-HIS6) and chicken or mouse polyclonal
antibodies against GFP (Chemicon) were used at 1:100 dilutions.
Texas Red-conjugated goat anti-rabbit and FITC conjugated
goat anti-chicken or anti-mouse secondary anti bodies (Jackson’s
lab) were used at a 1:100 dilution. For Western blot analysis,
antibodies were used at the following dilutions: anti-NCK-1 at
1:500, anti-VAB-1 at 1:2500, anti-MBP-HRP at 1:8000, anti-
GST-HRP at 1:4000 and 4G10 (Upstate Inc.) at 1:2500. Goat-
anti-rabbit-HRP and goat-anti-mouse-HRP were used as at
1:10000 dilutions on western blots. Relative band intensities
in Figure 6B were quantified using at least two independent
blots and analyzed using the National Institutes of Health Image
J program.
Phenotypic analysis
The mechanosensory neurons were visualized using the mec-
4::gfp (zdIs5) reporter. Young adult animals were scored as having
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previously [6]. Outgrowth of the PLM axon happens during
embryogenesis and continues to grow after hatching and most of
its growth happens at the L1 stage. From L2 onwards to adulthood
PLM growth is maintained relative to its termination point along
the body [28]. To measure the L1 PLM axons, newly hatched L1s
were synchronized in the absence of food for up to 12 hours. We
found that although the worms were born in the absence of food
that the PLM was still able to grow and the PLM axon lengths
were equivalent to the length of animals developing for 2–3 hours
post hatching. This corresponds to the Phase 1 or fast growth PLM
growth phase [28]. Our wild-type reference strain (zdIs5) had L1
PLMs with an average PLM length of 108.5 (65.5) microns with a
PLM length/total body length (from head to tail) ratio of 0.48
(60.04). L1 PLM axons were scored as overgrown if they were
longer than 114 mm and had a PLM/total body length ratio of
greater than 0.52. L1 PLM axons were scored as under grown if
the PLMs were shorter than 103 mm and had a PLM length/total
body length ratio of length less than 0.44. The L1 PLM axons
were traced from photograph and measured in NIH Image J
software. The wild-type neuron morphology was defined by
analysis of neuronal GFP reporters and is consistent with the
electron microscopic reconstruction of the C. elegans nervous
system [59]. Animals were anesthetized using 0.2% tricaine and
0.02% tetramisole in M9, and mounted on 3% agarose pads.
Unless stated otherwise, fluorescent animals and images were
analyzed using a Zeiss Axioplan microscope, Axiocam and
Axiovision software.
Time-lapse imaging of PLM growth cones
PLM growth cones were visualized using a mec-4::gfp (zdIs5)
reporter. Eggs were allowed to hatch for 5 minutes, and the newly
hatched L1 animals were examined immediately on 3% agarose
pads with a drop of 0.2% tricaine and 0.02% tetramisole in M9.
PLM growth cones were imaged with a Zeiss LSM710 confocal
microscope at intervals of 20–30 s. Axons were scored positive for
filopodia if time-lapse movies revealed at least 2 protrusions, and
there were dynamic movements (eg. growth and collapse) of the
these structures within the 10–15 minutes of filming. See Videos
S1 and S2 for examples.
Yeast two-hybrid assays
Yeast cells were grown on standard and selective media as
required [60]. The desired plasmids were transformed into yeast
cells using the lithium acetate method [61]. For binding and
deletion analysis, the pGBKT7 vector was used as bait and the
pGADT7 vector (Clontech) as prey, and b-galactosidase activity
was measured qualitatively by X-GAL overlay assays [62]. To
identify interactions with VAB-1, the Kinase Region (669 aa-
985 aa) of vab-1 was cloned into pGBKT7 (pIC187) and used in a
screen against the RB2 cDNA library (gift from Dr. R. Barstead),
and about 600,000 colonies were screened and two independent
nck-1 cDNA clones were isolated. Site directed mutagenesis
(QuickChange, Stratagene) of pIC187 was used to change the
juxtamembrane tyrosine 673 changed to glutamic acid (Y673E).
The SH2 domains of NCK-1, MIG-10, SEM-5, ABL-1 and VAV-
1 were cloned into the activation domain of the pGADT7 vector.
Primer sequences and details of plasmid constructs are available
upon request.
Pull down and co-purification assays
The following constructs were created by cloning the desired
cDNA fragment into Glutathione-S-Transferase (pGEX4T-2,
Amersham): pIC282 – NCK-1 SH2 domain (298 aa–397 aa),
pIC297 – all three NCK-1 SH3 domains (1 aa–308 aa), pIC308 –
1
st NCK-1 SH3 domain (1 aa–72 aa), pIC593 – 2
nd NCK-1 SH3
domain (112 aa–186 aa), pIC309 – 3
rd NCK-1 SH3 domain
(198 aa–308 aa), pIC324 – full length (F.L.) NCK-1 (1 aa–
397 aa), and pIC606 – F.L. UNC-34 (1 aa–454). The following
constructs were created by cloning the desired cDNA fragment
into Maltose Binding Protein (pMAL
tm-p2X, New England
Biolabs): pIC225 – F. L. intracellular region of wild-type VAB-1
(581 aa–1117 aa), pIC119 – F. L. intracellular kinase deficient
VAB-1 (G912E), pIC603 – UNC-34 RPO-EVH2 domain
(128 aa–454 aa), pIC605 – F.L. UNC-34 (1 aa–454 aa), pIC671
– UNC-34 PRO domain (128 aa–274), pIC674 – UNC-34 EVH2
domain (246 aa–454 aa), pIC670 – WSP-1 VCA domain (334 aa–
607 aa). pIC582 – His-6::VAB-1 (581 aa–1117 aa) was described
in Brisbin et al (2009). All fusion constructs were expressed in E.
coli Tuner (DE3). For Figure 4B, 4C, 4F, 4G and Figure 5A, a
GST ‘pull-down’ assay was used to confirm the VAB-1, NCK-1
and UNC-34 interactions. Soluble/purified (Load) MBP-VAB-1,
MBP-VAB-1(G912E), MBP-UNC-34 F.L., MBP-UNC-34-PRO-
EVH2, MBP-UNC-34-PRO or MBP-UNC-34-EVH2 were
incubated for 2–3 hrs at 4uC with soluble extracts containing
either GST, GST-NCK-1 F.L., GST-NCK-1-all SH3 domains,
GST-NCK-1(1
stSH3), GST-NCK-1(2
ndSH3), GST-NCK-
1(3
rdSH3), GST-NCK-1(SH2), His-6::VAB-1(581 aa–1117 aa)
(pIC582) or GST-NCK-1 F.L. coexpressed with pIC582 bound
to 50 ml glutathione sepharose beads (GE healthcare). Unbound
fractions were collected, protein bound to GST beads were
washed four times (25 mM Hepes, 10% Glycerol, 0.1% Triton-X,
285 mM NaCl), and a proportional loading of each sample was
analyzed by standard SDS polyacrlyamide gel, followed by
western blotting. All loads fused to MBP were detected using
anti-MBP conjugated to HRP (New England Biolabs). His6-
VAB-1 was detected using Rabbit anti-VAB-1 antibodies
(antigen VAB-1-His6) (Figure 5A). GST and GST-NCK-1 F.L.,
and GST-NCK-1 deletion domains were detected either by
Ponceau S or anti-GST conjugated to HRP. For Figure 6, MBP
‘pull-down’ was used to confirm VAB-1, NCK-1, WSP-1 and
UNC-34 interactions. Soluble extracts (Load) of GST-NCK-1
F.L., His-VAB-1 (pIC582), GST-NCK-1 F. L. coexpressed with
pIC582, or GST-UNC-34 F.L. were incubated for 2–3 hours
at 4uC with soluble extracts containing either MBP or MBP-
WSP-1(334 aa–608 aa) bound to 100 ml amylose resin beads
(New England Biolabs). Unbound fractions were collected,
protein bound to amylose beads were washed four times
(20 mM Tris-Cl [pH 7.5], 200 mM NaCl, 1 mM EDTA, 1 mM
DTT), and a proportional loading of each sample was analyzed
by standard SDS polyacrylamide gel, followed by western
blotting. VAB-1 was detected by Rabbit anti-VAB-1, GST
fused proteins were detected by anti-GST conjugated to HRP,
MBP and MBP-WSP were detected by anti-MBP conjugated
to HRP.
Supporting Information
Video S1 PLM growth cone of wild-type animals. Time-lapse
confocal imaging of wild-type (N2) PLM growth cone. Images
were taken at 30 s intervals for 15 minutes.
(MOV)
Video S2 PLM growth cone of hyperactive VAB-1 (myr-vab-1)
transgenic animals. Time-lapse confocal imaging of myr-vab-1
transgenic animals. Images were taken at 30 s intervals for
10 minutes.
(MOV)
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